An executive from Elevance has been ordered to testify in a case concerning alleged fraud in the Medicare Advantage program.
The Department of Justice claims that Elevance submitted inaccurate medical diagnoses to the government, resulting in fraudulent billing.
These allegations raise significant questions about the integrity of billing practices within the Medicare Advantage framework.